Position in NTRA
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$591,218
+$192,438 QoQ
Shares Held
2,178
+9.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#505
of 844 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $21,207,266 across 19 Diagnostics & Research names. NTRA ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,918 | $5,975,208 | |
| 2 | DHR |
Danaher Corp /De/
|
15,391 | $2,931,677 | |
| 3 | LH |
Labcorp Holdings Inc.
|
7,651 | $2,142,280 | |
| 4 | A |
Agilent Technologies, Inc.
|
9,423 | $1,251,657 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,125 | $1,118,685 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
5,581 | $1,078,360 | |
| 7 | ILMN |
Illumina, Inc.
|
5,103 | $897,260 | |
| 8 | NEO |
Neogenomics Inc
|
60,940 | $889,114 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $591,218 | 2,178 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $398,780 | 1,994 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $506,517 | 2,211 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $299,565 | 1,861 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $300,037 | 1,776 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $251,851 | 1,781 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $314,383 | 1,986 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $224,193 | 1,766 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||